Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Lamotrigine in Bipolar II Depression
NCT00074776Phase 3Completed
- Sponsor
- Stanford University
- Start
- May 2003
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lithium, lamotrigine in Bipolar II disorder (BP-II), sponsored by Stanford University. Started May 2003; status: completed.
02
Drugs
lithiumlamotrigine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00074776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074776.